A retrospective cohort study of venous thromboembolism(VTE) in 1035 Japanese myeloma patients treated with thalidomide; lower incidence without statistically significant association between specific risk factors and development of VTE and effects of thromboprophylaxis with aspirin and warfarin-Reference-Cited by-同舟云学术

A retrospective cohort study of venous thromboembolism(VTE) in 1035 Japanese myeloma patients treated with thalidomide; lower incidence without statistically significant association between specific risk factors and development of VTE and effects of thromboprophylaxis with aspirin and warfarin

Published:2013-02 Issue:2 Volume:131 Page:140-144
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Kato Atsushi,Takano Hina,Ichikawa Ayako,Koshino Mayuko,Igarashi Aiko,Hattori Keiichiro,Nagata Kaoru

Publisher

Elsevier BV

Subject

Hematology

Reference27 articles.

1. Venous thromboembolism in the patient with cancer. Focus on burden of disease and benefits of thromboprophylaxis;Lyman;Cancer,2011

2. Pathogenesis and management of bleeding and thrombosis in plasma cell dysclasias;Eby;Br J Haematol,2009

3. Prevension of thalidomide- and lenalidomide-associated thrombosis in myeloma;Palumbo;Leukemia,2008

4. Incidence and prophylaxis of venous thromboembolic events in multiple myeloma patients receiving immunomodulatory therapy;Musallam;Thromb Res,2009

5. Consensus guidelines for the optimal management of adverse events in newly diagnosed, transplant-ineligible patients receiving melphalan and prednisone in combination with thalidomide (MPT) for the treatment of multiple myeloma;Palumbo;Ann Hematol,2010

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence of thromboembolism and associated factors in multiple myeloma patients treated with immunomodulatory drugs: a retrospective analysis in Belo Horizonte, Brazil;Supportive Care in Cancer;2023-12-16

2. Development and validation of a new risk assessment model for immunomodulatory drug-associated venous thrombosis among Chinese patients with multiple myeloma;Thrombosis Journal;2023-10-04

3. Risk of thromboembolic events associated with different multiple myeloma regimens in Taiwan: a nested case-control study;Journal of Thrombosis and Thrombolysis;2023-09-22

4. Thrombosis events in Chinese patients with newly diagnosed multiple myeloma;Clinical and Experimental Medicine;2023-04-27

5. Platelet Parameters as Biomarkers for Thrombosis Risk in Cancer: A Systematic Review and Meta-analysis;Seminars in Thrombosis and Hemostasis;2023-03-15